CJC-1295 and Ipamorelin blend calculator
Research status: neither CJC-1295 nor Ipamorelin is an FDA-approved drug. This page does arithmetic on numbers you enter.
Treat each peptide in a blend separately: mcg of each peptide per unit = that peptide’s mg × 1,000 ÷ water mL ÷ 100. A blend label usually lists both amounts; the calculator shows what one unit and your draw contain of each.
Enter your vial label, water and units to see each peptide separately.
How long the vial lasts on your schedule
This calculator does arithmetic. It does not recommend an amount or a schedule.
mcg of each peptide per unit
Arithmetic only, not a dose recommendation. Each cell is the amount of each peptide in one U-100 unit, not the combined total.
| Blend label | 1 mL water | 2 mL water | 2.5 mL water | 3 mL water |
|---|---|---|---|---|
| 2 mg + 2 mg | 20 mcg each | 10 mcg each | 8 mcg each | 6.7 mcg each |
| 5 mg + 5 mg | 50 mcg each | 25 mcg each | 20 mcg each | 16.7 mcg each |
A common source of confusion: adding both peptides together gives a combined figure per unit that is double the per-peptide figure. Track the component you care about.
Planning an on/off schedule
Patterns like “5 days on, 2 off” appear in user guides. We found no clinical study that tested that schedule or the blend itself. The calculator above estimates how long a vial lasts on any pattern you enter, and the cycle planner in the app builds a 12-month calendar and pauses reminders on off days.
CJC-1295 with DAC vs without DAC
The published human studies of CJC-1295 used the long-acting form with the drug affinity complex (DAC), which binds albumin; it had an estimated half-life of 5.8–8.1 days (Teichman et al. 2006). Many blends instead use the form without DAC (often called Mod GRF 1-29), which those studies did not test. Check the label. See CJC-1295 (DAC) and CJC-1295 (no DAC).
What the research covers
| Study | Who / what | Finding |
|---|---|---|
| Teichman 2006 | Randomized, placebo-controlled; healthy adults; CJC-1295 with DAC | GH and IGF-I stayed raised for days after injection; no serious adverse reactions reported. |
| Ionescu & Frohman 2006 | Human study; CJC-1295 with DAC | GH kept its pulsatile pattern while trough GH levels rose. |
| Raun 1998 | Animal and in-vitro; ipamorelin | Released GH selectively without raising ACTH or cortisol in swine, unlike GHRP-6 and GHRP-2. Not a human study. |
| The blend | — | No published study of the combination found. |
Storage after mixing
We found no published in-use stability data for either peptide. See how long reconstituted peptides last for the general 28-day multiple-dose rule.
FAQ
How do you calculate units for a CJC-1295/Ipamorelin blend?
Is CJC-1295/Ipamorelin FDA-approved?
How long does a blend vial last on my schedule?
Can I combine two separate vials instead of a blend?
Sources
- Teichman et al. Prolonged stimulation of GH and IGF-I secretion by CJC-1295. J Clin Endocrinol Metab 2006 (PMID 16352683)
- Ionescu & Frohman. Pulsatile secretion of GH persists during continuous stimulation by CJC-1295. J Clin Endocrinol Metab 2006 (PMID 17018654)
- Raun et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol 1998 (PMID 9849822)
- USP General Chapter <797> revision notice (USP-NF, 2020)
Not medical advice. Talk to a clinician about any treatment.